Vascular Surgery was requested to see the patient on [**2108-2-8**] for abnormal peripheral vascular resistance studies which demonstrated significant superficial femoral artery tibial occlusive disease.
He is status post left first metatarsophalangeal joint resection with minimal bleeding.
The patient's ulcer is a chronic ulceration and he underwent resection and debridement.
PAST MEDICAL HISTORY:  End stage renal disease, status post renal transplant in [**2105-9-27**].
Coronary artery disease, status post angioplasty with stent in [**2105-10-28**].
Known peripheral vascular disease, right superficial femoral artery to tibial peroneal trunk, nonreverse saphenous vein graft in [**2105-2-25**], femoral peroneal to distal tibia with nonreverse cephalic in [**2105-4-27**] with a transmetatarsal ampicillin at that time.
MEDICATIONS ON ADMISSION:  Lopressor XL 100 mg q.d., Tylenol #3 for pain, Colace 100 mg b.i.d., Benadryl prn, Ambien at h.s.
prn, Zofran prn, subcutaneous heparin, Medzolin 2.5 mg q.d., Nuspan 500 mg q.d., Neurontin 100 mg t.i.d., Doxazosin 2 mg q.d., Lasix 60 mg q.d., Bactrim, Prednisone 20 mg q.d., Sirolimus 4 mg q.d., Lipitor 60 mg q.d.
Recommendation to consider arteriogram and cardiology consult for perioperative risk assessment, given the patient had diabetes, end stage renal disease and is status post renal transplant.
He was initially started on Vancomycin because cultures were read as Methicillin-resistant Staphylococcus aureus positive.
The patient was placed on Ceftazidime with Vancomycin.
Bactrim is for prophylaxis for immune suppression.
The patient underwent a Persantine MIBI with stress on [**2108-2-10**].
The external iliac was patent with a renal transplant off of the external iliac.
He tolerated the procedure well.
Postoperative day #1, he was continued on Vancomycin and Ciprofloxacin, secondary to his allergy to Penicillin.
His Dilaudid was continued, beta blocker was continued.
He was diuresed as needed and immune suppression was continued.
On postoperative day #2 the patient remained afebrile, his hematocrit was 29, BUN and creatinine 29 and 1.5, magnesium 1.9, Vancomycin 15.
The patient's lines were discontinued and he was transferred to the Regular Nursing Floor for continued care.
The patient underwent several other sharp excisional debridements at the bedside of the wound ulcer to clean the wound edges.
The patient underwent a delayed primary closure of the left foot on [**2108-2-20**], tolerating the procedure well.
A PICC line was placed for longterm antibiotics.
Our recommendations were to continue the nonweightbearing, continue the antibiotics and normal saline wet to dry dressings to the macerated area, and the keep monitoring wound healing.
DISCHARGE INSTRUCTIONS:  The patient should follow up with Dr. [**Last Name (STitle) **] in two weeks and the Podiatry Service at the same time for wound monitoring.
Length of antibiotic therapy potentially four to six weeks given that bone was affected.
Antibiotic agents to be determined by finalization on cultures.
Aspirin 81 mg q.d.
Amlodipine 10 mg q.d.
Atorvastatin 60 mg q.d.
Sirolimus 4 mg at bedtime 5.
Doxazosin 2 mg at bedtime 6.
Gabapentin 100 mg t.i.d.
Hespan 500 mg at h.s.
Colace 100 mg b.i.d.
Acetaminophen with codeine 1 to 2 tablets q.
Mycophenolate Mofetil 1000 mg t.i.d.
Bactrim single strength tablet one q.d.
Moprolol XL 125 mg q.d.
Insulin fixed and sliding scales, please see enclosed flow sheet 14.
Lasix 40 mg q.d.
Prednisone 10 mg q.d.
Neuropathic ischemic left foot ulceration, status post first metatarsophalangeal joint resection with multiple bedside debridement, skin edge eschar with delayed primary closure.
End stage renal disease, status post renal transplant of [**2105-2-25**], immune suppressed, stable.
Pseudomonal Staphylococcus coagulase positive wound and bone infection, intravenous antibiotics.
